Dr. Sven Jansen
Angestellt, Geschäftsführer, Neo Q Quality in Imaging GmbH
Berlin, Deutschland
Über mich
Dr. Sven Jansen is CEO of Neo Q Quality in Imaging GmbH, a Berlin-based AI-driven, guided reporting specialist in radiology. His scientific background is based on a Ph.D. in biochemistry/molecular medicine from the Harvard Medical School and the University of Bremen. He has over 20 years of experience in the Healthcare industry with different leading positions in international strategic consultancies like Booz Allen Hamilton, later booz&co., in Dubai and global healthcare companies like GE Healthcare in Paris & Chicago as well as CSC, later DXC Technology, in Germany. Until April 2022 he had been CEO and Executive Board Member of the Munich-based NOVENTI Group. Within the NOVENTI, he had been responsible for consumer & retail health. Dr. Jansen is book author, keynote-speaker and recipient of the LSC Leadership award of the Vatican. His engagement for planetary health & sustainability is internationally recognized. Sven holds various Advisory Board and Board of Director positions.
Werdegang
Berufserfahrung von Sven Jansen
Chief Executive Officer
Bis heute 2 Jahre, seit Juni 2022
Geschäftsführer
iNNO3 GmbH
Innovation, New Business & Sustainability
Bis heute 2 Jahre und 1 Monat, seit Mai 2022
Digital Health Executive
HoH
President & Managing Director
11 Monate, Juni 2022 - Apr. 2023
Geschäftsführer
INNO3 GmbH
4 Jahre und 9 Monate, Aug. 2017 - Apr. 2022
Aufsichtsrat
NOVENTI HealthFinance AG
Aufsichtsrat, Board of Directors
Vorstand New Business, Health Data Analytics & Sustainabulty
5 Jahre und 1 Monat, Apr. 2017 - Apr. 2022
Geschäftsführer
NOVENTI Group
Holding CEO, Member of the Board
5 Jahre und 1 Monat, Apr. 2017 - Apr. 2022
Geschäftsführer
NOVENTI Factory GmbH
Geschäftsführer, CEO
1 Jahr und 9 Monate, Juli 2015 - März 2017
Managing Partner Healthcare Consulting & Industry General Manager Healthcare
CSC / DXC Technology
1 Jahr und 9 Monate, Juli 2015 - März 2017
Industry General Manager Healthcare & Life Sciences CEE
CSC / DXC Technology
5 Jahre, Apr. 2012 - März 2017
Managing Partner, Head of Healthcare & Life Sciences Consulting
CSC / DXC Technology
2014 - 2015
Industry General Manager Healthcare & Life Sciences, CEE (acting)
CSC - Global Healthcare Group
1 Jahr, Apr. 2012 - März 2013
Director Consulting & Transformation, Global Strategy Lead
CSC / iSoft Health
Integrated Care strategy, Coordinated Healthcare 2.0, conception and implementation, regional and diagnosis-based population health managment, healthcare system transformation, eHealth strategy, conception and implementation, strategic disease marketing, Integrierte Versorgung (IV), Versorgungsmanagement, Versorgungssteuerung, Disease Management, Leistungskostensteuerung, sektorübergreifende Vernetzung, SGB V
2010 - 2012
Global Product Development Director Integrated Healthcare
GE Healthcare
Care coordination and integration based on quality and outcome, Healthsystem Management, Network Management, Regional Provider Management
2009 - 2011
EMEA Senior Consulting Manager, Business Leader Russia; Practice Leader Stroke
GE Healthcare
Consulting Manager EMEA; Business Leader Russia; Practice Leader Stroke. Business Development, IHO Development, Manager for consulting and advisory services for the healthcare industry (hospitals, payors & medtec) in the EMEA region. Strategic business development in the healthcare sector in EMEA. Subject matter expert for Payors (health insurances) and clinical pharmacology.
2009 - 2010
Consulting Manager Central Europe
GE Healthcare
Manager for consulting and advisory services for the healthcare industry (hospitals & medtec) in Central Europe. Strategic business development in the healthcare sector in Central Europe. Business Development, Subject matter expert for Payors (health insurances) and clinical pharmacology.
2007 - 2009
Manager
Booz & Company (former Booz Allen Hamilton)
Strategy/Management Consulting, Health Care Middle East
2005 - 2007
Senior Consultant
B-LUE Management Consulting
project leader in strategy/management consulting with major emphasis on the health care sector (health insurances, bio- and life sciences, biotech, medical, hospitals)
2004 - 2006
Consultant
RGE Unternehmensberatung
consultant financial services (insurances)
2001 - 2004
Projektleiter
Kooperationszentrum Medizin Bremen - Klinikum Bremen Mitte
project leader R&D (research, clinical trials, clinical pathways)
Ausbildung von Sven Jansen
biochemistry
UCSD, The Burnham Institute La Jolla/San Diego
signal transduction, cellular aging
- Bis heute
biochemistry/molecular medicine
UCSD, Scripps Research Center Torry Pines and La Jolla/San Diego
signal transduction, cellular signalling
- Bis heute
biochemistry/molecular medicine, clinical trials
Kooperationszentrum Medizin Bremen, Klinikum Bremen-Mitte
signal transduction, cellular signalling, clinical trials
biochemistry/molecular psychiatry
Monash University Melbourne/Australia
signal transduction, cellular signalling
biochemistry/neurobiochemistry
Universität Bremen - Center for Biomolecular Interactions
signal transduction, cellular signalling, neurometallobiochemistry (EGF-/IGF-pathway, insulin mimetic effects, kinases, phosphatases, Zn-/Ca-induced signalling, second messenger, apoptosis, PDEs, cAMP/cGMP-pathways, zinc-sensing-receptor (ZnR), zinc-transport (ZnT/ZIP), ROS-signalling)
biochemistry/molecular medicine
University of California San Diego Medical School
signal transduction, cellular signalling (EGF-/IGF-pathway, insulin mimetic effects, kinases, phosphatases, Zn-/Ca-induced signalling, second messenger, apoptosis, PDEs, cAMP/cGMP-pathways, zinc-sensing-receptor (ZnR), zinc-transport (ZnT/ZIP), ROS-signalling)
biochemistry/molecular medicine
Harvard Medical School, Harvard University Boston/USA
signal transduction, cellular signalling (EGF-/IGF-pathway, insulin mimetic effects, kinases, phosphatases, Zn-/Ca-induced signalling, second messenger, apoptosis, PDEs, cAMP/cGMP-pathways, zinc-sensing-receptor (ZnR), zinc-transport (ZnT/ZIP), ROS-signalling)
Sprachen
Deutsch
-
Englisch
-
Französisch
-